Spore Biotechnologies develops microbiological tools that enhance manufacturing processes by ensuring product safety through precise microbial control and monitoring. The company addresses the challenge of contamination in industrial production, enabling factories to produce safer products efficiently.
Funding
$8.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
+5Founders
Product
Problem
Traditional microbiological quality control methods in manufacturing, which often rely on techniques like Petri dishes, can be slow and labor-intensive, leading to delays in product release and potential safety risks. These conventional methods may take days to yield results, hindering timely intervention and potentially allowing contaminated products to proceed further in the supply chain.
Solution
Spore Biotechnologies is developing an AI-powered, light-based technology for instant microbiological analysis, enabling rapid detection and identification of microbial contamination in manufacturing environments. Their technology aims to replace or augment traditional methods by providing real-time insights into product safety. By combining biophotonics and machine learning, Spore's solution accelerates the quality control process, reducing the time required for microbial detection from days to near-instantaneous results. This allows manufacturers to quickly identify and address contamination issues, ensuring product safety and minimizing potential disruptions to production. The technology is designed to be integrated into existing manufacturing workflows, providing a seamless and efficient solution for microbiological quality control.
Target Audience
Spore Biotechnologies targets manufacturers in industries such as food and beverage, pharmaceuticals, and cosmetics who require rapid and accurate microbiological quality control to ensure product safety and regulatory compliance.
Features
- AI-driven analysis of microbiological samples
- Biophotonics-based detection technology
- Rapid, near-instantaneous results compared to traditional methods
- Integration with existing manufacturing quality control processes
- Detection and identification of a wide range of microbial contaminants
- Data analytics and reporting capabilities for trend analysis and process optimization